Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study

Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study

Abstract Background Weekly paclitaxel + ramucirumab (wPTX + RAM) therapy is recommended as the standard second-line chemotherapy regimen for unresectable advanced/recurrent gastric cancer (GC) or esophagogastric junction cancer. Recent subgroup analysis of the RAINBOW trial revealed a higher frequen...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Katsuhiko Nara, Takehito Yamamoto, Hiroharu Yamashita, Koichi Yagi, Tappei Takada, Yasuyuki Seto, Hiroshi Suzuki
Natura:	Articolo
Lingua:	English
Pubblicazione:	BMC 2023-10-01
Serie:	BMC Cancer
Soggetti:	Weekly paclitaxel + ramucirumab Febrile neutropenia Oxaliplatin Total bilirubin Gastric/Esophagogastric cancer
Accesso online:	https://doi.org/10.1186/s12885-023-11469-y

Documenti analoghi

Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
di: Keita Miura, et al.
Pubblicazione: (2024-02-01)

Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer
di: Kosuke Hamai, et al.
Pubblicazione: (2023-04-01)

How I treat febrile neutropenia
di: Marcio Nucci
Pubblicazione: (2021-02-01)

La neutropenia
di: Efraín Pulla Cadmilema, et al.
Pubblicazione: (2023-08-01)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
di: Doaa Naeem, et al.
Pubblicazione: (2018-08-01)

Febrile Neutropenia Due To Brucellosis: Case Report
di: Abdullah Sakin, et al.
Pubblicazione: (2012-06-01)

Il costo di una neutropenia febbrile
di: C. Lucioni, et al.
Pubblicazione: (2005-03-01)

Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases
di: Sang Ngoc Nguyen, et al.
Pubblicazione: (2022-08-01)

Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy
di: Maria Bachlitzanaki, et al.
Pubblicazione: (2023-10-01)

Chemotherapy Induced Neutropenia, Febrile-Neutropenia and Determinants Among Solid Cancer Patients Attending Oncology Unit of a Tertiary Care Teaching Hospital in Ethiopia
di: Dessalegn M, et al.
Pubblicazione: (2023-02-01)

Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6
di: Razan Zatarah, et al.
Pubblicazione: (2022-10-01)

Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
di: Müge ASLAN, et al.
Pubblicazione: (2014-12-01)

Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)
di: Naoki Takahashi, et al.
Pubblicazione: (2023-08-01)

The cost effectiveness of the respiratory virus panel in childhood febrile neutropenia
di: Hüsamettin Vatansev, et al.
Pubblicazione: (2023-03-01)

Chemotherapy limiting neutropenia. Is prevention required?
di: I. B. Kononenko, et al.
Pubblicazione: (2022-01-01)

Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH
di: Marcio Nucci, et al.
Pubblicazione: (2024-12-01)

Secondary Infections in Cancer Patients with Febrile Neutropenia
di: Alpay Azap, et al.
Pubblicazione: (2012-08-01)

Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
di: Sylvie Lorenzen, et al.
Pubblicazione: (2023-06-01)

Thrombin generation in children with febrile neutropenia
di: Ayça Koca Yozgat, et al.
Pubblicazione: (2021-04-01)

Clozapine-Induced Febrile Neutropenia and Cellulitis
di: Selcuk YAYLACI, et al.
Pubblicazione: (2014-03-01)

Caracterización de los pacientes que ingresan a UCIP por neutropenia febril Clínica Prevenir Barranquilla 2015 –2016
di: Malvin Medina Caicedo
Pubblicazione: (2017-12-01)

Prevalencia de gérmenes con multirresistencia antibiótica en bacteriemia asociada a neutropenia febril en pacientes oncológicos hospitalizados
di: Carlos Soliz Poveda, et al.
Pubblicazione: (2022-08-01)

Mortalidad de Pacientes Oncológicos vinculados a Neutropenia
di: Carlos García Cruz, et al.
Pubblicazione: (2019-04-01)

Doente com Neutropenia Febril: Uma Intervenção Especializada – Revisão Integrativa da Literatura
di: Cristina Santos, et al.
Pubblicazione: (2021-06-01)

Risk factors associated with sepsis in children with acute lymphoblastic leukemia and febrile neutropenia
di: An nieza Dea Versary, et al.
Pubblicazione: (2024-06-01)

Febrile neutropenia management in pediatric onco-hematologic patients: a systematic review
di: Tatiane Bertella, et al.
Pubblicazione: (2021-10-01)

Febrile neutropenia recurrence after chemotherapy in patients with breast cancer
di: Simone Yuriko Kameo, Glebson Moura Silva, Namie Okino Sawada, Mary Elizabeth de Santana
Pubblicazione: (2020-10-01)

Analyse of Febrile Neutropenia Attacks in Children with Acute Lymphoblastic Leukemia
di: Meriban Karadoğan, et al.
Pubblicazione: (2023-09-01)

Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia
di: Keegan Peter Janssens, et al.
Pubblicazione: (2021-05-01)

EVALUATION OF ANTIBIOTIC IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH FEBRILE NEUTROPENIA
di: Ambar Yunita Nugraheni, et al.
Pubblicazione: (2020-04-01)

Etiología bacteriana y susceptibilidad antibiótica en adultos con leucemias agudas y neutropenia febril con factores de alto riesgo
di: Jonathan Darío Ortega Calderón, et al.
Pubblicazione: (2021-04-01)

Re-thinking treatment strategies for febrile neutropenia in paediatric oncology population: the perspective from a developing country
di: Vinson James, et al.
Pubblicazione: (2021-06-01)

Effect of an education program on knowledge, self-care behavior and handwashing competence on prevention of febrile neutropenia among breast cancer patients receiving Doxorubicin and Cyclophosphamide in Chemotherapy Day Centre
di: Wai Chi Mak, et al.
Pubblicazione: (2015-01-01)

The Value of C-Reactive Protein and Procalcitonin in Febrile Neutropenia
di: Solmaz Çelebi, et al.
Pubblicazione: (2009-06-01)

PERFIL DE PACIENTES HEMATOLÓGICOS COM NEUTROPENIA FEBRIL: ESTUDO OBSERVACIONAL
di: Raphael Braz de Carvalho, et al.
Pubblicazione: (2023-08-01)

The effect of leptin gene polymorphisms (LEP rs7799039 and LEPR rs1137101) on febrile neutropenia
di: Ezgi Paslı Uysalol, et al.
Pubblicazione: (2024-04-01)

Management of febrile neutropenia: A description of clinical and microbiological findings by focusing on risk factors and pitfalls
di: Fatemeh Karimi, et al.
Pubblicazione: (2018-01-01)

La neutropenia severa febril en niños con cáncer: Estudio descriptivo en el Hospital Universitario de Santander Severe febrile neutropenia in children with cancer: A descriptive study at the Hospital Universitario de Santander
di: Ernesto Rueda, et al.
Pubblicazione: (2010-08-01)

Serum endocan levels in children with febrile neutropenia
di: Eylem Kiral, et al.
Pubblicazione: (2016-03-01)

Lipegfilgrastim in patients with chemotherapy-induced neutropenia
di: G. D. Petrova, et al.
Pubblicazione: (2015-12-01)